|Mr. Howard S. Jonas||Founder & Chairman||250k||N/A||1956|
|Mr. Menachem Ash||Pres & Gen. Counsel||350.08k||N/A||1972|
|Mr. David A. Polinsky||Chief Financial Officer||276.5k||N/A||1972|
|Dr. Ameet Mallik||CEO & Director||N/A||N/A||N/A|
|Mr. William Conkling||Chief Commercial Officer||N/A||N/A||N/A|
|Ms. Joyce J. Mason Esq.||Corp. Sec.||N/A||N/A||1959|
Rafael Holdings, Inc. owns commercial real estate assets and interests in pre-clinical and clinical stage pharmaceutical companies. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Rafael Holdings, Inc.’s ISS Governance QualityScore as of June 1, 2021 is 9. The pillar scores are Audit: 8; Board: 9; Shareholder Rights: 9; Compensation: 8.